Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y C Lou

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Cancer Gene Therapy|March 17, 1999
Complementary adenoviral vectors for oncolysisR Alemany, S Lai, Y C Lou, et al.
Journal of Biomolecular NMR|May 29, 2000
Solution structure of the human BTK SH3 domain complexed with a proline-rich peptide from p120cblS R Tzeng, Y C Lou, M T Pai, et al.
Journal of Biomolecular NMR|September 8, 1998
Local helix content and RNA-binding activity of the N-terminal leucine-repeat region of hepatitis delta antigenJ W Cheng, I J Lin, Y C Lou, et al.
Journal of Virological Methods|December 6, 1997
Complementation of helper-dependent adenoviral vectors: size effects and titer fluctuationsR Alemany, Y Dai, Y C Lou, et al.
International Journal of Cancer|April 21, 1999
Genetic polymorphism of xenobiotic metabolizing enzymes among Chinese lung cancer patientsI Persson, I Johansson, Y C Lou, et al.
The Journal of Biological Chemistry|November 3, 1995
The promiscuous chemokine binding profile of the Duffy antigen/receptor for chemokines is primarily localized to sequences in the amino-terminal domainZ H Lu, Z X Wang, R Horuk, et al.
Methods in Enzymology|January 1, 1996
Genetic and biochemical approaches for analysis of mitochondrial RNase P from Saccharomyces cerevisiaeK R Groom, Y L Dang, G J Gao, et al.
Archives of Biochemistry and Biophysics|December 22, 1999
Solution structure and dynamics of G1TE, a nonphosphorylated cyclic peptide inhibitor for the Grb2 SH2 domainY C Lou, F D Lung, M T Pai, et al.
Scientia Sinica. Series B, Chemical, Biological, Agricultural, Medical & Earth Sciences|August 1, 1983
Mechanism of interferon action III--significance of pppA2'p5'A2'p5'A in the antiviral action of interferonX Y Liu, K Yao, Y X Zhou, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|December 22, 2025
[Research progress on the lung cancer risk prediction models]S J Wu, H Ye, C B Lin, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Cancer Gene Therapy|March 17, 1999
Complementary adenoviral vectors for oncolysisR Alemany, S Lai, Y C Lou, et al.
Journal of Biomolecular NMR|May 29, 2000
Solution structure of the human BTK SH3 domain complexed with a proline-rich peptide from p120cblS R Tzeng, Y C Lou, M T Pai, et al.
Journal of Biomolecular NMR|September 8, 1998
Local helix content and RNA-binding activity of the N-terminal leucine-repeat region of hepatitis delta antigenJ W Cheng, I J Lin, Y C Lou, et al.
Journal of Virological Methods|December 6, 1997
Complementation of helper-dependent adenoviral vectors: size effects and titer fluctuationsR Alemany, Y Dai, Y C Lou, et al.
International Journal of Cancer|April 21, 1999
Genetic polymorphism of xenobiotic metabolizing enzymes among Chinese lung cancer patientsI Persson, I Johansson, Y C Lou, et al.
The Journal of Biological Chemistry|November 3, 1995
The promiscuous chemokine binding profile of the Duffy antigen/receptor for chemokines is primarily localized to sequences in the amino-terminal domainZ H Lu, Z X Wang, R Horuk, et al.
Methods in Enzymology|January 1, 1996
Genetic and biochemical approaches for analysis of mitochondrial RNase P from Saccharomyces cerevisiaeK R Groom, Y L Dang, G J Gao, et al.
Archives of Biochemistry and Biophysics|December 22, 1999
Solution structure and dynamics of G1TE, a nonphosphorylated cyclic peptide inhibitor for the Grb2 SH2 domainY C Lou, F D Lung, M T Pai, et al.
Scientia Sinica. Series B, Chemical, Biological, Agricultural, Medical & Earth Sciences|August 1, 1983
Mechanism of interferon action III--significance of pppA2'p5'A2'p5'A in the antiviral action of interferonX Y Liu, K Yao, Y X Zhou, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|December 22, 2025
[Research progress on the lung cancer risk prediction models]S J Wu, H Ye, C B Lin, et al.
Pageof 3